Nuedexta and Memantine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nuedexta (dextromethorphan hydrobromide; quinidine sulfate) and Memantine (memantine). Common drug interactions include drug ineffective among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Nuedexta and Memantine. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Nuedexta?

Nuedexta has active ingredients of dextromethorphan hydrobromide; quinidine sulfate. eHealthMe is studying from 3,781 Nuedexta users. Check the latest studies of Nuedexta.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

41 people who take Nuedexta and Memantine together, and have interactions are studied.

Nuedexta and Memantine drug interactions.

What are the common drug interactions of Nuedexta and Memantine, by gender? *:

female:

  1. Drug ineffective
  2. Urinary tract infection
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Breast mass
  6. Fatigue (feeling of tiredness)
  7. Immunosuppression
  8. Nausea (feeling of having an urge to vomit)
  9. Pneumonia
  10. Pulmonary haemorrhage (acute bleeding from the lung)

male:

  1. Confusional state
  2. Dizziness
  3. Speech disorder
  4. Agitation (state of anxiety or nervous excitement)
  5. Anger
  6. Asthenia (weakness)
  7. Bacterial test positive
  8. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  9. Depression
  10. Disease recurrence

What are the common drug interactions of Nuedexta and Memantine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Affect lability (emotional incontinence)
  2. Affective disorder (mental disorder)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Irritability
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Micturition urgency (urgency to pass the urine)
  9. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

40-49:

  1. Fatigue (feeling of tiredness)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Stress

50-59:

  1. Breast mass
  2. Drug ineffective
  3. Nausea (feeling of having an urge to vomit)
  4. Urinary tract infection
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Arthropathy
  9. Asthenia (weakness)
  10. Balance disorder

60+:

  1. Death
  2. Immunosuppression
  3. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  4. Insomnia (sleeplessness)
  5. Micturition urgency (urgency to pass the urine)
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Speech disorder
  8. Weight decreased
  9. Aggression
  10. Anger

What are the existing conditions these people have? *

  1. Affect Lability (emotional incontinence): 9 people, 21.95%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 19.51%
  3. Parkinson's Disease: 7 people, 17.07%
  4. Depression: 6 people, 14.63%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 14.63%
  6. Stress And Anxiety: 6 people, 14.63%
  7. Muscle Spasms (muscle contraction): 5 people, 12.20%
  8. Dementia (madness): 5 people, 12.20%
  9. High Blood Pressure: 5 people, 12.20%
  10. Migraine (headache): 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Nuedexta and Memantine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nuedexta and Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuedexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nuedexta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Memantine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan hydrobromide; quinidine sulfate and memantine (the active ingredients of Nuedexta and Memantine, respectively), and Nuedexta and Memantine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: